abstract |
The present invention relates to antisense constructs, particularly antisense nucleic acids and hammerhead ribozymes, which are specific for transcripts encoded by chromosomal translocations, such as the bcr-abl fusion as well as to pharmaceutical compositions containing said antisense constructs. |